MAVILIO, Fulvio
 Distribuzione geografica
Continente #
NA - Nord America 13.796
EU - Europa 5.317
AS - Asia 2.403
SA - Sud America 28
OC - Oceania 9
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.568
Nazione #
US - Stati Uniti d'America 13.745
GB - Regno Unito 1.593
IT - Italia 768
CN - Cina 763
RU - Federazione Russa 747
SG - Singapore 727
SE - Svezia 717
HK - Hong Kong 514
DE - Germania 415
FI - Finlandia 291
UA - Ucraina 225
BG - Bulgaria 212
TR - Turchia 161
FR - Francia 150
ID - Indonesia 80
IE - Irlanda 52
VN - Vietnam 52
BE - Belgio 43
JP - Giappone 31
CA - Canada 27
IN - India 27
NL - Olanda 22
BR - Brasile 21
BZ - Belize 17
SI - Slovenia 14
IR - Iran 13
LT - Lituania 13
CH - Svizzera 8
GR - Grecia 8
PL - Polonia 8
AU - Australia 7
DK - Danimarca 7
ES - Italia 7
KR - Corea 5
MY - Malesia 5
RO - Romania 5
CL - Cile 4
CZ - Repubblica Ceca 4
EU - Europa 4
MX - Messico 4
PH - Filippine 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IL - Israele 3
TH - Thailandia 3
BO - Bolivia 2
GH - Ghana 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MA - Marocco 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BW - Botswana 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
IQ - Iraq 1
KZ - Kazakistan 1
NO - Norvegia 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 21.568
Città #
Fairfield 2.044
Santa Clara 1.834
Southend 1.212
Woodbridge 1.087
Ashburn 965
Chandler 951
Houston 925
Wilmington 654
Seattle 647
Cambridge 623
Ann Arbor 596
Singapore 564
Hong Kong 510
Jacksonville 499
Nyköping 455
Dearborn 386
San Diego 262
Beijing 242
Modena 239
Princeton 219
Sofia 211
Helsinki 209
Bremen 119
London 109
Eugene 102
Jakarta 80
Izmir 73
Shanghai 65
New York 63
Des Moines 62
Dong Ket 52
Dublin 52
Milan 47
Brussels 43
Moscow 42
San Jose 40
Redwood City 38
Norwalk 35
Boardman 29
Bonndorf 29
Falls Church 27
Hounslow 26
Los Angeles 24
Kilburn 22
Chicago 19
Frankfurt am Main 18
Hefei 18
Nanjing 18
Rome 18
Belize City 17
Guangzhou 16
Kocaeli 16
Paris 16
San Francisco 14
Toronto 14
Wuhan 14
Prescot 13
Porretta Terme 12
Bari 11
Buffalo 11
Camden 11
Chiswick 11
Hangzhou 11
Ottawa 11
Bologna 10
Phoenix 10
Ranchi 10
Kunming 9
Redmond 9
Catania 8
Las Vegas 8
Padova 8
Valsamoggia 8
Kinde 7
Turin 7
Verona 7
Indiana 6
Parma 6
Pasadena 6
Perugia 6
Philadelphia 6
Saint Louis 6
Trieste 6
Argenta 5
Auburn Hills 5
Casagiove 5
Castelfranco Emilia 5
Chengdu 5
Ferrara 5
Fremont 5
Fuzhou 5
Munich 5
Nanchang 5
Penne 5
Savignano Sul Rubicone 5
Southwark 5
Albuquerque 4
Augusta 4
Basel 4
Brooklyn 4
Totale 17.026
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 821
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 283
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 243
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 243
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 241
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 229
Nuclear architecture dictates HIV-1 integration site selection 225
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 222
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 218
Mechanisms of retroviral integration and mutagenesis 217
Tracking gene-modified T cells in vivo. 216
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 215
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 211
A single epidermal stem cell strategy for safe ex vivo gene therapy 204
Medicina rigenerativa e nuove frontiere terapeutiche 201
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 199
Site-specific integration into the human genome: Ready for clinical application? 196
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 195
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 194
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 191
Gene therapy of skin adhesion disorders (mini review) 189
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 188
Gene therapy approaches for epidermolysis bullosa 187
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 186
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 186
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 181
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 181
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 180
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 180
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 180
Defining the lentiviral integrome in human hematopoietic cells 180
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 179
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 176
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 175
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 173
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 173
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 172
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 172
Muscle-derived hematopoietic stem cells are hematopoietic in origin 171
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 170
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. 169
Gene therapies need new development models 167
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 165
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 165
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 165
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 164
Comprehensive genomic access to vector integration in clinical gene therapy. 164
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 162
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 161
Repairing without cutting: A safer alternative to gene correction? 161
Gene therapy of inherited skin adhesion disorders: a critical overview 160
Safety of retroviral gene marking with a truncated NGF receptor 160
Stem cell plasticity: time for a reappraisal? 159
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 159
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 157
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 157
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 155
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 155
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 155
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 153
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 152
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 150
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 150
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 149
Site-specific integration by the adeno-associated virus rep protein 148
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 147
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 147
Perspectives on Best Practices for Gene Therapy Programs 145
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 145
Towards a gene therapy clinical trial for epidermolysis bullosa 144
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 144
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 142
Interactions between Retroviruses and the Host Cell Genome 140
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 138
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 137
Clonal analysis of stably transduced human epidermal stem cells in culture. 137
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 134
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 133
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 133
Gene therapy: back on track? 130
Epithelial stem cells in corneal regeneration and epidermal gene therapy. [5YIF: 6.94; Citations: 68] 128
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 126
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 124
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 124
Toward gene therapy of junctional epidermolysis bullosa (JEB) 123
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 123
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 123
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy 121
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 119
The future of gene therapy 117
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 110
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 110
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 110
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 109
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 107
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 106
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 105
The Pharmacology of Gene and Cell Therapy 101
Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates 97
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency 85
Totale 16.869
Categoria #
all - tutte 125.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.124 0 0 0 0 0 486 486 337 341 154 185 135
2020/20213.460 322 114 166 284 417 317 215 342 322 439 314 208
2021/20223.677 389 358 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20252.947 187 55 68 494 1.324 819 0 0 0 0 0 0
Totale 21.900